In a regulatory filing, Cue Biopharma (CUE) disclosed that on June 4, Kerri-Ann Millar notified the company that she is resigning from her position as Chief Financial Officer, effective June 13. Effective June 13, Daniel Passeri, the company’s Chief Executive Officer, will serve as the company’s principal financial and accounting officer on an interim basis until a new principal financial and accounting officer is designated, the filing stated.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CUE:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue